Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
NEVRO CORP (NVRO)
|
Add to portfolio |
|
|
|
| Price: |
$85.27
| | Metrics |
| OS: |
35.4
|
M
| |
-50
|
% ROE
|
| Market cap: |
$3.02
|
B
| |
-31
|
% ROIC
|
|
Net cash:
|
$311
|
M
| |
$8.78
|
per share
|
|
EV:
|
$2.71
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
($107)
|
M
| |
|
|
| EPS |
($3.26)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 386.9 | 362.0 | 390.3 | 387.3 | 326.7 | 228.5 | 69.6 | 32.6 |
| Revenue growth | 6.9% | -7.2% | 0.8% | 18.6% | 43.0% | 228.3% | 113.7% | 38.6% |
| Cost of goods sold | 120.9 | 112.1 | 121.9 | 114.0 | 99.0 | 75.4 | 28.1 | 11.3 |
| Gross profit | 266.0 | 249.9 | 268.4 | 273.3 | 227.7 | 153.1 | 41.5 | 21.3 |
| Gross margin | 68.8% | 69.0% | 68.8% | 70.6% | 69.7% | 67.0% | 59.6% | 65.4% |
| Selling, general and administrative | 309.3 | 267.2 | 305.8 | 266.6 | 219.7 | 142.4 | 82.5 | 29.8 |
| Research and development | 47.7 | 45.6 | 59.0 | 48.5 | 37.6 | 33.7 | 21.4 | 19.8 |
| EBIT | -90.9 | -62.9 | -96.5 | -41.7 | -29.6 | -23.1 | -62.4 | -28.3 |
| EBIT margin | -23.5% | -17.4% | -24.7% | -10.8% | -9.1% | -10.1% | -89.6% | -86.9% |
| Pre-tax income | -130.8 | -82.2 | -102.1 | -48.4 | -35.3 | -30.2 | -66.3 | -30.2 |
| Income taxes | 0.5 | 0.9 | 1.6 | 0.8 | 1.4 | 1.6 | 1.2 | 0.5 |
| Net income | -131.4 | -83.1 | -103.7 | -49.2 | -36.7 | -31.8 | -67.4 | -30.8 |
| Net margin | -34.0% | -22.9% | -26.6% | -12.7% | -11.2% | -13.9% | -96.9% | -94.6% |
| |
| Diluted EPS | ($3.77) | ($2.47) | ($3.37) | ($1.64) | ($1.25) | ($1.12) | ($2.53) | ($6.87) |
| Shares outstanding (diluted) | 34.8 | 33.7 | 30.8 | 30.1 | 29.4 | 28.5 | 26.6 | 4.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|